← Back to all trials
Recruiting
NCT06513819
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Conditions: Hiv, Alcohol Drinking, Fall, Cannabis Use
Sex: All
Ages: 50 Years – N/A
Healthy volunteers: No
Phase: PHASE1
Enrollment: 100
Sponsor: Yale University
Location: VA Connecticut Healthcare System West Haven Connecticut
Summary
The focus of this pilot will be on falls and neurocognitive symptoms, and the impact of alcohol, cannabis use, and medications on these outcomes. The rationale is that alcohol use at any level may interact with neurocognitively active medications, alcohol, and cannabis use leading to falls and impaired cognition.
Eligibility Criteria
Inclusion Criteria:
* HIV+
* have visited a local VA site in within the past year
* had an AUDIT-C indicating current alcohol use
* taking 5 or more non-ART medications, including an NCAM (i.e., benzodiazepines, opioids, muscle relaxants, sleeping medication, and selective serotonin reuptake inhibitors)
Exclusion Criteria:
* Inpatient individuals
* Patients with an Alcohol Use Disorder (AUD) diagnosis in the past 12 months
* Patients who test positive on the Alcohol Symptom Checklist for moderate or severe AUD during the screening process
Source: ClinicalTrials.gov (NCT06513819). StuddyBuddy aggregates publicly available trial information.
